Godavari Drugs Ltd
Ticker: GODAVARI
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
87.19
Market Cap
65.66
Debt/Equity
1.4844
ROE %
10.641
PB
1.5146
Promoter %
52.609
Pledge %
0.113
1Y Rev Growth %
-27.331
5Y Rev Growth %
3.550
NP Margin %
3.831
NP Margin 5Y Avg %
3.262
Trading Reference
1M Return %
1.995
6M Return %
-2.045
1Y Return %
-29.056
% Away 52W High
53.573
% Away 52W Low
10.493
Daily Volume
11061
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Godavari Drugs Ltd shows potential for growth amid industry challenges.
✅ Positives
- Strong revenue growth in recent quarters
- Diversified product portfolio
- Strategic partnerships enhancing market reach
⚠️ Negatives
- High competition in the pharmaceutical sector
- Regulatory challenges affecting operations
- Volatility in raw material prices
Verdict
Cautiously optimistic about future performance.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
U
Unison Metals Ltd
Unison Metals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Salasar Exteriors and Contour Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Annvrridhhi Ventures Ltd
The stock presents several risks, including inconsistent growth and weak profitability metrics, making it a risky investment.
View details
P
Palred Technologies Ltd
Palred Technologies Ltd shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
D
Deep Diamond India Ltd
Deep Diamond India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vinny Overseas Ltd
Vinny Overseas Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shanmuga Hospital Ltd
Shanmuga Hospital Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
View details
N
Novelix Pharmaceuticals Ltd
Novelix Pharmaceuticals Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
S
Shiva Mills Ltd
Shiva Mills Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
M
Mega Nirman & Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
J
Jet Freight Logistics Ltd
Jet Freight Logistics Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability, making it a risky investment.
View details
C
Continental Petroleums Ltd
Continental Petroleums Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
S
SVC Industries Ltd
SVC Industries Ltd shows some potential but faces significant challenges in growth and profitability metrics.
View details
A
AGS Transact Technologies Ltd
AGS Transact Technologies Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
A
Ajcon Global Services Ltd
The stock presents several risks with limited growth prospects and weak financial metrics, making it a risky investment.
View details
R
Rodium Realty Ltd
Rodium Realty Ltd shows potential in a growing sector, but faces challenges in profitability and valuation, warranting cautious observation.
View details
Business Overview
Godavari Drugs Ltd is a leading Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates. Catering to both domestic and international markets, it plays a crucial role in the healthcare sector by ensuring the availability of high-quality medicines. The company is committed to innovation and sustainability, making it a trusted partner for pharmaceutical companies globally. With a strong focus on research and development, Godavari Drugs Ltd is well-positioned to meet the growing demand for affordable healthcare solutions.
- Established leader in pharmaceutical manufacturing
- Focus on Active Pharmaceutical Ingredients (APIs)
- Strong commitment to quality and compliance
- Innovative research and development initiatives
- Serves both domestic and international markets
Investment Thesis
Godavari Drugs Ltd presents a compelling investment opportunity, backed by a strong and credible promoter group. The company's focus on expanding digital services positions it well for future growth. Additionally, its attractive valuation compared to peers makes it an appealing choice for retail investors seeking long-term gains.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services sector.
- Attractive valuation metrics compared to industry peers.
- Solid fundamentals and growth strategy indicate long-term viability.
- Favorable market conditions support the company's expansion plans.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical products
- Expansion into new markets
- Strong R&D pipeline
- Strategic partnerships with healthcare providers
- Increasing exports potential
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependence on key customers
- Fluctuating raw material costs
Peer Perspective
Godavari Drugs Ltd trades at a discount to peers like Aarti Industries and Alkyl Amines, primarily due to margin volatility. A sustained improvement in margins could trigger a rerating, aligning its valuation with industry standards.
Future Outlook
Godavari Drugs Ltd is well-positioned for growth in the pharmaceutical sector, provided it maintains strong execution and cost control. Continued innovation and market expansion could enhance shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Godavari Drugs Ltd do?A: Godavari Drugs Ltd is involved in the manufacturing of pharmaceutical products and active pharmaceutical ingredients.
- Q: Is Godavari Drugs Ltd listed on the stock exchange?A: Yes, Godavari Drugs Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What are the key financials to consider?A: Investors should review revenue growth, profit margins, and debt levels in the company's financial statements.
- Q: How can I invest in Godavari Drugs Ltd?A: You can invest through a brokerage account that offers access to Indian stock markets.
- Q: What are the risks associated with investing in Godavari Drugs Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Godavari Drugs Ltd • Updated: 2025-09-16 21:04:16
-
8BusinessHighThe pharmaceutical sector is growing, but Godavari's niche may limit its moat.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow sometimes lagging behind net profit.
-
9ValuationHighValuation metrics are average compared to peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodGrowth drivers are limited, with execution risks in scaling operations.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Godavari Drugs Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100